Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Jul;10(4):308-18.
doi: 10.1007/s11910-010-0120-8.

Update on anticonvulsant drugs

Derek J Chong  1 , Carl W Bazil
Affiliations
Review

Update on anticonvulsant drugs

Derek J Chong et al. Curr Neurol Neurosci Rep. 2010 Jul.

Abstract

In 2009, the US Food and Drug Administration approved three medications for the treatment of epilepsy: rufinamide, lacosamide, and vigabatrin. In addition, extended-release formulations of lamotrigine and levetiracetam were approved recently. When added to the dozen medications for treating epilepsy, the choice is a luxury in terms of additional options, but also a challenge for practitioners to use them all with expertise. Recently, there has been much interest surrounding medications for epilepsy and their possible association with osteoporosis, safety during pregnancy, biological equivalence to generic versions, and possible association with higher rates of suicidality. This review discusses these issues and provides a current overview for the medical management of epilepsy.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Epilepsia. 2009 May;50(5):978-86 - PubMed
    1. Epilepsia. 2009 Aug;50(8):1899-909 - PubMed
    1. Neurology. 2008 May 20;70(21):1950-8 - PubMed
    1. Lancet. 2007 Mar 24;369(9566):1000-15 - PubMed
    1. J Eur Acad Dermatol Venereol. 2008 Sep;22(9):1044-9 - PubMed

Substances